Filed: 5/13/2025ACC: 0001766721-25-000003
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $288.45M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$288.45M
Total AUM (reported)
18.49M
Total Shares
Allocation by class
COM$239.71M83.1%
SPONSORED ADS$42.50M14.7%
COM CL A$4.85M1.7%
COM NEW$1.40M0.5%
Portfolio Concentration
Top 3$261.43M90.6%
4–10$25.58M8.9%
11–25$1.45M0.5%
Top 3 weight
90.6%
Top 10 weight
99.5%
Voting Authority Distribution
Total shares with voting rights: 18.49M
Sole
Full voting authority
18.49M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
BridgeBio Pharma Inc. (BBIO)
SOLEShares6.07M
TypeSH
Market value$209.78M
72.72%
Sole
6.07M
Shared
0.00
None
0.00
Verona Pharma plc (VRNA)
SOLEShares615.35K
TypeSH
Market value$39.07M
13.54%
Sole
615.35K
Shared
0.00
None
0.00
Syndax Pharmaceuticals, Inc. (SNDX)
SOLEShares1.02M
TypeSH
Market value$12.59M
4.36%
Sole
1.02M
Shared
0.00
None
0.00
Bicara Therapeutics Inc. (BCAX)
SOLEShares568.92K
TypeSH
Market value$7.41M
2.57%
Sole
568.92K
Shared
0.00
None
0.00
Monte Rosa Therapeutics Inc (GLUE)
SOLEShares1.47M
TypeSH
Market value$6.83M
2.37%
Sole
1.47M
Shared
0.00
None
0.00
Nuvation Bio Inc. (NUVB)
SOLEShares2.54M
TypeSH
Market value$4.47M
1.55%
Sole
2.54M
Shared
0.00
None
0.00
Compass Pathways Plc (CMPS)
SOLEShares1.20M
TypeSH
Market value$3.43M
1.19%
Sole
1.20M
Shared
0.00
None
0.00
Biomea Fusion Inc (BMEA)
SOLEShares798.76K
TypeSH
Market value$1.70M
0.59%
Sole
798.76K
Shared
0.00
None
0.00
CalciMedica, Inc. (CALC)
SOLEShares521.11K
TypeSH
Market value$995.3K
0.35%
Sole
521.11K
Shared
0.00
None
0.00
Elevation Oncology Inc (ELEV)
SOLEShares2.83M
TypeSH
Market value$734.5K
0.25%
Sole
2.83M
Shared
0.00
None
0.00
Aclaris Therapeutics Inc (ACRS)
SOLEShares434.45K
TypeSH
Market value$664.7K
0.23%
Sole
434.45K
Shared
0.00
None
0.00
Marker Therapeutics, Inc. (MRKR)
SOLEShares325.37K
TypeSH
Market value$400.2K
0.14%
Sole
325.37K
Shared
0.00
None
0.00
OnKure Therapeutics, Inc. (OKUR)
SOLEShares88.61K
TypeSH
Market value$381.0K
0.13%
Sole
88.61K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO)SOLE | COM | 6.07M | SH | $209.78M 72.72% | 6.07M | 0.00 | 0.00 |
Verona Pharma plc (VRNA)SOLE | SPONSORED ADS | 615.35K | SH | $39.07M 13.54% | 615.35K | 0.00 | 0.00 |
Syndax Pharmaceuticals, Inc. (SNDX)SOLE | COM | 1.02M | SH | $12.59M 4.36% | 1.02M | 0.00 | 0.00 |
Bicara Therapeutics Inc. (BCAX)SOLE | COM | 568.92K | SH | $7.41M 2.57% | 568.92K | 0.00 | 0.00 |
Monte Rosa Therapeutics Inc (GLUE)SOLE | COM | 1.47M | SH | $6.83M 2.37% | 1.47M | 0.00 | 0.00 |
Nuvation Bio Inc. (NUVB)SOLE | COM CL A | 2.54M | SH | $4.47M 1.55% | 2.54M | 0.00 | 0.00 |
Compass Pathways Plc (CMPS)SOLE | SPONSORED ADS | 1.20M | SH | $3.43M 1.19% | 1.20M | 0.00 | 0.00 |
Biomea Fusion Inc (BMEA)SOLE | COM | 798.76K | SH | $1.70M 0.59% | 798.76K | 0.00 | 0.00 |
CalciMedica, Inc. (CALC)SOLE | COM NEW | 521.11K | SH | $995.3K 0.35% | 521.11K | 0.00 | 0.00 |
Elevation Oncology Inc (ELEV)SOLE | COM | 2.83M | SH | $734.5K 0.25% | 2.83M | 0.00 | 0.00 |
Aclaris Therapeutics Inc (ACRS)SOLE | COM | 434.45K | SH | $664.7K 0.23% | 434.45K | 0.00 | 0.00 |
Marker Therapeutics, Inc. (MRKR)SOLE | COM NEW | 325.37K | SH | $400.2K 0.14% | 325.37K | 0.00 | 0.00 |
OnKure Therapeutics, Inc. (OKUR)SOLE | COM CL A | 88.61K | SH | $381.0K 0.13% | 88.61K | 0.00 | 0.00 |